HCW Biologics is trading now at $2.50, up 8.23%, as biotechnology shares strengthen broadly.
- No new company-specific announcement dated August 25, 2026 was identified; the latest listed release was its August 14 second-quarter update.
- An August 20 Form S-1 resale registration was filed, but it predates the move and does not clearly explain the gain.
- Sector momentum is the best attribution, with XBI up 2.06%.